Department of Pharmaceutics, Virginia Commonwealth University, 410 N 12th Street, Richmond, VA 23298, USA.
Evid Based Complement Alternat Med. 2012;2012:872458. doi: 10.1155/2012/872458. Epub 2012 Jul 15.
Many active components of herbal products are small organic anions, and organic anion transporters were previously demonstrated to be a potential site of drug-drug interactions. In this study, we assessed the inhibitory effects of six hydrophilic components of the herbal medicine Danshen, lithospermic acid, protocatechuic acid, rosmarinic acid, salvianolic acid A, salvianolic acid B, and tanshinol, on the function of the murine organic anion transporters, mOat1 and mOat3. All of Danshen components significantly inhibited mOat1- and mOat3-mediated substrate uptake (P < 0.001) with lithospermic acid (LSA), protocatechuic acid, rosmarinic acid (RMA), and salvianolic acid A (SAA) producing virtually complete inhibition under test conditions. Kinetic analysis demonstrated that LSA, RMA, and SAA were competitive inhibitors. As such, K(i) values were estimated as 14.9 ± 4.9 μM for LSA, 5.5 ± 2.2 μM for RMA, and 4.9 ± 2.2 μM for SAA on mOat1-mediated transport, and as 31.1 ± 7.0 μM for LSA, 4.3 ± 0.2 μM for RMA, and 21.3 ± 7.7 μM for SAA on mOat3-mediated transport. These data suggest that herb-drug interactions may occur in vivo on the human orthologs of these transporters in situations of polypharmacy involving Danshen and clinical therapeutics known to be organic anion transporter substrates.
许多草药产品的活性成分都是小分子有机阴离子,而有机阴离子转运体先前被证实是药物相互作用的潜在作用部位。在这项研究中,我们评估了草药丹参的六种亲水性成分(丹酚酸 B、迷迭香酸、原儿茶酸、咖啡酸、丹参素和丹参醇)对鼠有机阴离子转运体 mOat1 和 mOat3 功能的抑制作用。所有丹参成分均显著抑制 mOat1 和 mOat3 介导的底物摄取(P < 0.001),丹酚酸 B(LSA)、原儿茶酸、迷迭香酸(RMA)和丹参素 A(SAA)在测试条件下几乎完全抑制。动力学分析表明 LSA、RMA 和 SAA 是竞争性抑制剂。因此,LSA、RMA 和 SAA 对 mOat1 介导的转运的 K(i)值分别估计为 14.9 ± 4.9 μM、5.5 ± 2.2 μM 和 4.9 ± 2.2 μM,而对 mOat3 介导的转运的 K(i)值分别估计为 31.1 ± 7.0 μM、4.3 ± 0.2 μM 和 21.3 ± 7.7 μM。这些数据表明,在涉及丹参的多药治疗和已知是有机阴离子转运体底物的临床治疗的情况下,这些转运体的人类同源物在体内可能会发生草药-药物相互作用。